3723: Early Cancer Detection Test From Home (TT)

Dr. Stephen Cabral discusses the critical importance of early colon cancer detection through at-home lab tests, emphasizing that colon cancer is the third most common cancer and second leading cause of cancer death in the U.S., with rising rates among people under 50. He highlights two key at-home tests: Cologuard, a multi-target stool DNA test covered by insurance for those over 45, which detects cancer with 92% sensitivity but has a 13% false positive rate; and the FIT test, an over-the-counter fecal immunochemical test with 95% specificity and lower false positives but higher false negatives (25–30%). Dr. Cabral advocates for annual FIT testing alongside colonoscopies every 5–10 years, especially for those pursuing high-performance health. He stresses that early detection can lead to a 90%+ five-year survival rate, making preventative testing a cornerstone of proactive health. The episode concludes with a plug for his curated resource page at stephencabral.com/resources for trusted health products.